Christopher Viehbacher, new Biogen CEO

Bio­gen se­lects new CEO: for­mer Sanofi head Chris Viehbach­er

Bio­gen’s months-long search for a new CEO land­ed on the choice of for­mer Sanofi CEO Chris Viehbach­er, who was pre­vi­ous­ly oust­ed from his top spot at the French com­pa­ny.

Viehbach­er will be step­ping in­to Bio­gen at a tu­mul­tuous mo­ment as its first Alzheimer’s drug Aduhelm failed at launch with­out pay­er cov­er­age, but its next up-and-com­ing amy­loid-tar­get­ed drug lecanemab shows promise in re­cent­ly re­leased re­sults that could amount to a full ap­proval.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.